🔎 Trials Near Me

Akèy › Ateroskleroz › Arizona › Phoenix

Etid klinik pou Ateroskleroz nan Phoenix, AZ

5 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3
  • Onyx Clinical Research, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Synexus Clinical Research US, Inc., Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3
  • AKDHC Medical, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Phoenix
  • Research Site, Phoenix
  • Research Site, Phoenix
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Ap rekriteFaz 4
  • Phoenix VA Health Care System, Phoenix, AZ, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198

Etid Ateroskleroz nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.